The global medical linac market is growing at a CAGR of over 7% during the forecast period 2023-2033.
Rising prevalence of cancer worldwide, along with rapid technological advancements and rising medical costs are expected to boost the market growth. The LINAC is considered a breakthrough device that has revolutionized treatment due to its cost-effectiveness. In addition, there has been a major shift in the delivery of cancer care as the trend has shifted from invasive to non-invasive treatments. Non-invasive treatments include radiation therapy, which is the most advanced and cost-effective treatment modality for patients. Radiation therapy helps treat a wide variety of cancers and can be used alone or in combination with surgery, chemotherapy, or other treatments. This staggering shift in consumer expectations has therefore increased the acceptance of medical Linux devices.
For more information, please download the PDF sample: https://www.sdki.jp/sample-request-91593
The emergence of artificial intelligence is revolutionizing the medical imaging equipment market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming linac-based cancer treatment. Vendors are therefore focused on developing AI- and ML-enabled oncology LINACs, which are likely to become a useful treatment option in the years to come.
The following factors are expected to contribute to the growth of the medical linac market during the forecast period:
- High prevalence of cancer -
Increasing demand for non-invasive cancer treatments
- Emergence of MRI-based linear accelerators
- High penetration of robotic radiotherapy
The study considers the current scenario of the medical linac market and the market dynamics from 2023 to 2033.
It covers a detailed overview of several market growth enablers, inhibitors and trends. It covers both the demand and supply side of the market. We profile and research major companies and other prominent companies operating in the market.
Medical Linear Accelerator Market Segmentation
This research report includes detailed segmentation by product, application, end-user and region. The rapid adoption and increasing incidence of radiotherapy with medical linac machines for the treatment of breast cancer is a factor in the growth of this segment. With the increase in breast cancer, the demand for advanced treatment options such as radiotherapy devices that effectively destroy malignant cells at high targets is expected to increase.
Lung cancer treatment is projected to achieve the highest revenue due to rapid global growth. Therefore, the application of linac-mediated radiotherapy for these treatments may gain a favorable share of the market. The growing use of external beam radiation therapy (EBRT) has led to prominent vendors offering advanced LINAC systems for lung cancer treatment.
The medical linac field is growing due to the increasing incidence of cancer worldwide and the growing demand for advanced digital radiotherapy equipment. The use of an innovative oncology informatics platform has enabled rapid advances in radiotherapy planning, saving time and reducing costs.
Details here @ https://www.sdki.jp/reports/medical-linear-accelerators-market/91593
Oncology informatics is driving the demand for digital solutions and linac integration to aid in better planning of radiotherapy and improve cancer treatment efficacy and patient outcomes. The integration of radiation oncology and informatics/software is changing the dynamics of treatment by providing end-users with smart and efficient tools to perfectly receive, transmit and store electronic information. be.
The hospital segment is expected to dominate the global medical linac market, while the cancer treatment center segment is expected to grow at the highest CAGR during the forecast period. The high adoption rate of advanced radiotherapy equipment such as linacs is due to the fact that the majority of patients prefer to visit hospitals that provide advanced radiotherapy infrastructure to receive cancer treatment.
Market Segment by Product-
Devices- Market Segment by
Oncology Informatics/Software
Application-
Breast Cancer-
Prostate Cancer-
Lung Cancer-
Head and Neck Cancer-
Colorectal Cancer-
Other
Market Segment by End-User
-Hospitals-
Oncology Centers-
Academic and Research Center
Regional Market Segment
- North America
o United States
o Canada
- APAC
o Japan
o China
o South Korea
o Australia
o India
- Europe
o Germany
o France
o UK
Spain
o Italy
- Latin America
o Brazil
o Mexico
o Argentina
- MEA
o Turkey
o Saudi Arabia
o UAE
Analysis of key vendors in the
global market